Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a significant decline in short interest during the month of March. As of March 15th, there was short interest totalling 3,000 shares, a decline of 46.4% from the February 29th total of 5,600 shares. Based on an average daily volume of 8,100 shares, the short-interest ratio is currently 0.4 days.

Alpha Tau Medical Stock Performance

Shares of NASDAQ:DRTSW traded down $0.01 during midday trading on Thursday, hitting $0.25. 850 shares of the stock traded hands, compared to its average volume of 7,312. Alpha Tau Medical has a one year low of $0.14 and a one year high of $0.45. The business’s 50 day moving average is $0.27 and its two-hundred day moving average is $0.26.

Hedge Funds Weigh In On Alpha Tau Medical

A number of institutional investors and hedge funds have recently made changes to their positions in DRTSW. Polar Asset Management Partners Inc. purchased a new stake in Alpha Tau Medical during the first quarter valued at approximately $134,000. Walleye Capital LLC bought a new position in Alpha Tau Medical during the first quarter valued at $112,000. Chicago Partners Investment Group LLC bought a new position in Alpha Tau Medical during the first quarter valued at $55,000. Walleye Trading LLC bought a new position in Alpha Tau Medical during the first quarter valued at $65,000. Finally, Jane Street Group LLC bought a new position in Alpha Tau Medical during the first quarter valued at $64,000.

About Alpha Tau Medical

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.